loading
前日終値:
$1.74
開ける:
$1.74
24時間の取引高:
439.45K
Relative Volume:
0.62
時価総額:
$64.91M
収益:
$832.00K
当期純損益:
$-135.12M
株価収益率:
-0.2931
EPS:
-6.09
ネットキャッシュフロー:
$-124.69M
1週間 パフォーマンス:
+0.85%
1か月 パフォーマンス:
-7.03%
6か月 パフォーマンス:
-68.90%
1年 パフォーマンス:
-81.56%
1日の値動き範囲:
Value
$1.74
$1.9192
1週間の範囲:
Value
$1.675
$1.9192
52週間の値動き範囲:
Value
$1.42
$13.44

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Name
名前
Inovio Pharmaceuticals Inc
Name
セクター
Healthcare (1152)
Name
電話
(858) 410-3134
Name
住所
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Name
職員
134
Name
Twitter
@inoviopharma
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
INO's Discussions on Twitter

INO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
INO
Inovio Pharmaceuticals Inc
1.79 64.91M 832.00K -135.12M -124.69M -6.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.53 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.26 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
598.41 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
231.49 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.96 26.16B 3.81B -644.79M -669.77M -6.24

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-14 開始されました Stephens Overweight
2024-01-25 アップグレード Oppenheimer Perform → Outperform
2022-11-09 ダウングレード Maxim Group Buy → Hold
2022-11-01 ダウングレード BofA Securities Neutral → Underperform
2022-07-19 再開されました RBC Capital Mkts Sector Perform
2022-05-11 ダウングレード Oppenheimer Outperform → Perform
2022-01-21 アップグレード BofA Securities Underperform → Neutral
2021-12-29 再開されました Jefferies Hold
2021-09-10 ダウングレード BofA Securities Neutral → Underperform
2021-06-24 開始されました Jefferies Hold
2021-03-23 開始されました BofA Securities Neutral
2021-02-12 開始されました Oppenheimer Outperform
2020-11-17 ダウングレード ROTH Capital Neutral → Sell
2020-11-10 アップグレード ROTH Capital Sell → Neutral
2020-09-28 ダウングレード Cantor Fitzgerald Overweight → Neutral
2020-09-28 アップグレード Maxim Group Hold → Buy
2020-07-01 ダウングレード Maxim Group Buy → Hold
2020-07-01 ダウングレード ROTH Capital Neutral → Sell
2020-06-29 ダウングレード H.C. Wainwright Buy → Neutral
2020-06-26 ダウングレード Stifel Buy → Hold
2020-05-21 開始されました The Benchmark Company Buy
2020-04-30 ダウングレード ROTH Capital Buy → Neutral
2020-03-13 ダウングレード Piper Sandler Overweight → Neutral
2020-03-13 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2019-12-19 開始されました ROTH Capital Buy
2018-02-15 繰り返されました Maxim Group Buy
2017-10-18 開始されました RBC Capital Mkts Outperform
2017-09-06 開始されました Citigroup Buy
2017-06-08 アップグレード Piper Jaffray Neutral → Overweight
2017-05-24 繰り返されました Maxim Group Buy
2017-03-16 アップグレード Maxim Group Hold → Buy
2017-03-16 ダウングレード Piper Jaffray Overweight → Neutral
すべてを表示

Inovio Pharmaceuticals Inc (INO) 最新ニュース

pulisher
07:40 AM

Bet on These 5 Top-Ranked Stocks With Rising P/E - Nasdaq

07:40 AM
pulisher
Apr 17, 2025

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial - ADVFN

Apr 17, 2025
pulisher
Apr 17, 2025

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Apr 17, 2025
pulisher
Apr 16, 2025

Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 16, 2025
pulisher
Apr 14, 2025

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 14, 2025
pulisher
Apr 11, 2025

Inovio Pharmaceuticals Inc. stock rises Friday, still underperforms market - MarketWatch

Apr 11, 2025
pulisher
Apr 11, 2025

INOVIO to Highlight Breakthrough Immunotherapy Data at AACR Conference - MSN

Apr 11, 2025
pulisher
Apr 11, 2025

INOVIO to Showcase Breakthrough Data on INO-3107 at Major Industry Conferences - MyChesCo

Apr 11, 2025
pulisher
Apr 10, 2025

Inovio (INO) Upgraded to Buy: Here's What You Should Know - MSN

Apr 10, 2025
pulisher
Apr 10, 2025

INOVIO Reports Inducement Grant Under Inducement Plan - MarketScreener

Apr 10, 2025
pulisher
Apr 10, 2025

Next-generation Covid-19 vaccines currently being tested - Yahoo Finance

Apr 10, 2025
pulisher
Apr 09, 2025

Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 09, 2025
pulisher
Apr 09, 2025

INOVIO to Present at Upcoming Scientific Conferences | INO Stock News - GuruFocus

Apr 09, 2025
pulisher
Apr 09, 2025

INOVIO to Present at Upcoming Scientific Conferences - Longview News-Journal

Apr 09, 2025
pulisher
Apr 09, 2025

INOVIO's Breakthrough: 72% Success in HPV TreatmentMultiple Conference Spotlights - Stock Titan

Apr 09, 2025
pulisher
Apr 08, 2025

Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Apr 08, 2025
pulisher
Apr 07, 2025

Inovio stock touches 52-week low at $1.47 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Inovio stock touches 52-week low at $1.47 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 04, 2025

Inovio Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch

Apr 04, 2025
pulisher
Apr 04, 2025

Inovio Pharmaceuticals to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013 - ACCESS Newswire

Apr 04, 2025
pulisher
Apr 02, 2025

HPV Market to Reach $10.8 Bn, Globally, by 2031 at 12.4% CAGR | - openPR.com

Apr 02, 2025
pulisher
Apr 01, 2025

Down -11.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO) - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 31, 2025
pulisher
Mar 31, 2025

Sector Update: Health Care - MarketScreener

Mar 31, 2025
pulisher
Mar 28, 2025

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Mar 28, 2025
pulisher
Mar 26, 2025

Inovio stock plunges to 52-week low at $1.74 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Inovio stock plunges to 52-week low at $1.74 amid market challenges - Investing.com Australia

Mar 26, 2025
pulisher
Mar 25, 2025

Lassa Fever Market Anticipated to Expand Rapidly During 2024-2034, Says DelveInsight | Inovio Pharma - Barchart.com

Mar 25, 2025
pulisher
Mar 22, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 22, 2025
pulisher
Mar 21, 2025

INOVIO Reports Progress on INO-3107 and DNA Medicine, 2024 Financial Outcomes - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Mar 20, 2025
pulisher
Mar 20, 2025

Inovio’s SWOT analysis: dna firm’s stock faces crucial year ahead By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

DNA Vaccines Market and Their Impact on Global Health: Trends & - openPR.com

Mar 20, 2025
pulisher
Mar 19, 2025

Inovio’s SWOT analysis: dna firm’s stock faces crucial year ahead - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Inovio taking on Covid-19 again, almost 3 years after abandoning vaccine effort - Philadelphia Business Journal

Mar 19, 2025
pulisher
Mar 19, 2025

Inovio aims for INO-3107 regulatory submission by mid-2025 while addressing key manufacturing issues - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

RBC Cuts Price Target on Inovio Pharmaceuticals to $5 From $6, Keeps Sector Perform, Speculative Risk - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo

Mar 19, 2025
pulisher
Mar 19, 2025

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus

Mar 19, 2025
pulisher
Mar 19, 2025

Earnings call transcript: Inovio Q4 2024 sees narrowed losses, strategic focus - Investing.com Australia

Mar 19, 2025

Inovio Pharmaceuticals Inc (INO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$19.85
price down icon 0.77%
$71.22
price down icon 2.53%
$32.51
price up icon 0.11%
$24.83
price down icon 0.47%
$97.38
price down icon 1.48%
biotechnology ONC
$231.14
price up icon 0.63%
大文字化:     |  ボリューム (24 時間):